Cargando…

Identification and Construction of a Predictive Immune-Related lncRNA Signature Model for Melanoma

OBJECTIVE: The occurrence and development mechanisms of melanoma are related to immunity and lncRNAs. Therefore, it is necessary to systematically explore immune-related lncRNA profiles to help improve the prognosis of melanoma. METHODS: We integrated immune-related lncRNAs and the basic clinical in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Fang-Wei, Luo, Sheng-Kang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647169/ https://www.ncbi.nlm.nih.gov/pubmed/34880662 http://dx.doi.org/10.2147/IJGM.S340025

Ejemplares similares

Identification and validation of immune‐related lncRNA prognostic signatures for melanoma
por: Xiao, Bo, et al.
Publicado: (2021)

Construction of five cuproptosis-related lncRNA signature for predicting prognosis and immune activity in skin cutaneous melanoma
por: Yang, Xiaojing, et al.
Publicado: (2022)

Construction of disulfidptosis-related lncRNA signature for predicting the prognosis and immune escape in colon adenocarcinoma
por: Chen, Pan, et al.
Publicado: (2023)

Construction of an immune‐related LncRNA signature with prognostic significance for bladder cancer
por: Luo, Wen‐Jie, et al.
Publicado: (2021)

Construction of an Immune-Related lncRNA Signature That Predicts Prognosis and Immune Microenvironment in Osteosarcoma Patients
por: He, Yi, et al.
Publicado: (2022)

Tumor microenvironment immune-related lncRNA signature for patients with melanoma
por: Guo, Jia-Hui, et al.
Publicado: (2021)

Immune-related lncRNA pairs as novel signature to predict prognosis and immune landscape in melanoma patients
por: Li, Zhehong, et al.
Publicado: (2022)

Immune-Related lncRNA to Construct Novel Signature and Predict the Immune Landscape of Human Hepatocellular Carcinoma
por: Hong, Weifeng, et al.
Publicado: (2020)

A Novel Signature Constructed by Immune-Related LncRNA Predicts the Immune Landscape of Colorectal Cancer
por: Sun, Mengyu, et al.
Publicado: (2021)

Constructing an immune‐ and ferroptosis‐related lncRNA signature to predict the immune landscape of human bladder cancer
por: Li, Xing, et al.
Publicado: (2022)

Construction and validation of a glycolysis-related lncRNA signature for prognosis prediction in Stomach Adenocarcinoma
por: Liao, Tianyou, et al.
Publicado: (2022)

Identification of hub gene and lncRNA signature related to entotic cell death in cutaneous melanoma for prognostic and immune prediction
por: Zhang, Chen, et al.
Publicado: (2023)

Identification and Validation of Immune-Related lncRNA Signature as a Prognostic Model for Skin Cutaneous Melanoma
por: Ping, Shuai, et al.
Publicado: (2021)

Construction of an immune-related lncRNA signature as a novel prognosis biomarker for LUAD
por: Chen, Hang, et al.
Publicado: (2021)

Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma
por: Yu, Wanli, et al.
Publicado: (2021)

Construction of immune-related lncRNA signature to predict aggressiveness, immune landscape, and drug resistance of colon cancer
por: Xue, Yonggan, et al.
Publicado: (2022)

Construction of a cuproptosis‐related lncRNA signature for predicting prognosis and immune landscape in osteosarcoma patients
por: Ni, Shumin, et al.
Publicado: (2022)

Construction and validation of cuproptosis-related lncRNA prediction signature for bladder cancer and immune infiltration analysis
por: Li, Hanrong, et al.
Publicado: (2023)

Identification of m7G-associated lncRNA prognostic signature for predicting the immune status in cutaneous melanoma
por: Rong, Jielin, et al.
Publicado: (2022)

Identification of a Seven-lncRNA Immune Risk Signature and Construction of a Predictive Nomogram for Lung Adenocarcinoma
por: Jin, Donghui, et al.
Publicado: (2020)

Using Immune-Related lncRNA Signature for Prognosis and Response to Immunotherapy in Cutaneous Melanoma
por: Xue, Ling, et al.
Publicado: (2021)

Construction of a Novel Lung Adenocarcinoma Immune-Related lncRNA Pair Signature
por: Qi, Xiangjun, et al.
Publicado: (2021)

Identification of Immune-Related lncRNA Pairs and Construction and Validation of a New Prognostic Signature of Colon Cancer
por: Xu, Minxian, et al.
Publicado: (2022)

Construction of a novel necroptosis-related lncRNA signature for prognosis prediction in esophageal cancer
por: Liu, Yang, et al.
Publicado: (2022)

Identification and Validation of a Novel Immune-Related lncRNA Signature for Bladder Cancer
por: Hua, Shan, et al.
Publicado: (2021)

Construction of implantation failure related lncRNA-mRNA network and identification of lncRNA biomarkers for predicting endometrial receptivity
por: Feng, Chun, et al.
Publicado: (2018)

Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinoma
por: Deng, Min, et al.
Publicado: (2021)

Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma
por: Xu, Yujian, et al.
Publicado: (2022)

An Immune-Related lncRNA Signature to Predict the Biochemical Recurrence and Immune Landscape in Prostate Cancer
por: Zhang, Guian, et al.
Publicado: (2021)

Identification of an Immune-Related Nine-lncRNA Signature Predictive of Overall Survival in Colon Cancer
por: Lin, Yilin, et al.
Publicado: (2020)

Identification of Immune-Related lncRNA Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
por: Zhang, Lianghao, et al.
Publicado: (2021)

Identification and Validation of an Immune-Related lncRNA Signature to Facilitate Survival Prediction in Gastric Cancer
por: Ma, Ensi, et al.
Publicado: (2021)

Identification and Validation of an EMT-Related LncRNA Signature for HNSCC to Predict Survival and Immune Landscapes
por: Feng, Chunyu, et al.
Publicado: (2022)

Identification of an Iron Metabolism-Related lncRNA Signature for Predicting Osteosarcoma Survival and Immune Landscape
por: Hong-bin, Shao, et al.
Publicado: (2022)

Identification of prognostic immune-related lncRNA signature predicting the overall survival for colorectal cancer
por: Li, Jianxin, et al.
Publicado: (2023)

Identification and validation of an anoikis-related lncRNA signature to predict prognosis and immune landscape in osteosarcoma
por: Zhang, Jun-Song, et al.
Publicado: (2023)

Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma
por: Xu, Zhijie, et al.
Publicado: (2021)

Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma
por: Qin, Yuan, et al.
Publicado: (2022)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients
por: Jiang, Zi-Rong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kf8f9b061j5b66bs8sdi48qoc1